孟河医派安胎核心方治疗先兆流产合并绒毛膜下血肿患者临床疗效观察  

Clinical efficacy Observation of Menghe Medicine School Antai Hexin Decoction in Treatment of Patients with Threatened Abortion and Subchorionic Hematoma

作　　者：潘赟琰 符圆圆[1] 李淑萍[1] PAN Yunyan;FU Yuanyuan;LI Shuping(Changzhou Hospital of Traditional Chinese Medicine,Jiangsu Changzhou 213004,China)

机构地区：[1]江苏省常州市中医医院,江苏常州213004

出　　处：《中医药临床杂志》2023年第11期2232-2235,共4页Clinical Journal of Traditional Chinese Medicine

基　　金：2021年常州市重点研发计划(CJ20210158);李淑萍名中医工作室(常卫中医[2018]252号);江苏省中医临床重点专科(苏中医政[2011]70号)。

摘　　要：目的:观察孟河医派安胎核心方联合地屈孕酮治疗先兆流产合并绒毛膜下血肿患者的临床疗效。方法:采用回顾性研究的方法,收集2021年3月—2022年6月江苏省常州市中医医院妇科收治的145例先兆流产合并绒毛膜下血肿患者,根据是否使用孟河医派安胎核心方将患者分为对照组和观察组。对照组采用地屈孕酮口服治疗,共73例,观察组在此基础上给予孟河医派安胎核心方口服,共72例。比较2组治疗前后的临床疗效、中医证候评分、血肿大小及妊娠结局等指标。结果:观察组治疗有效率90.28%,高于对照组71.23%(P<0.05);治疗后,2组中医症状积观察组优于对照组(P<0.05);治疗后2组血肿均减小,且观察组优于对照组(P<0.05)。结论:孟河医派安胎核心方联合地屈孕酮治疗先兆流产合并绒毛膜下血肿是一种安全的方法,提高了治疗有效率,减轻相关临床伴随症状,且无明显不良反应。Objective:To observe the clinical efficacy of Menghe Medical School’s Toy Core Formula combined with dydrogesterone in the treatment of patients with threatened abortion and subchorionic hematoma.Methods:A retrospective study was conducted to collect 145 patients with threatened abortion complicated with subchorionic hematoma who were admitted to the Department of Gynecology,Changzhou Traditional Chinese Medicine Hospital,Jiangsu Province from March 2021 to June 2022.The patients were divided into control group and observation group.The control group was treated with dydrogesterone orally,a total of 73 cases.On this basis,the observation group was treated with Menghe Medical School’s tocolysis core prescription,a total of 72 cases.Compare the clinical efficacy,TCM syndrome scores,hematoma size,pregnancy outcomes and other indicators between the 2 groups before and after treatment.Results:The treatment effective rate of the observation group was 90.28%,which was higher than that of the control group 71.23%(P<0.05);after treatment,the TCM symptom volume of the two groups in the observation group was better than that of the control group(P<0.05);after treatment,the hematomas in both groups were reduced.,and the observation group was better than the control group(P<0.05).Conclusion:Menghe Medical School’s tocolysis core formula combined with dydrogesterone is a safe method to treat threatened abortion complicated by subchorionic hematoma,which improves the treatment efficiency,reduces related clinical symptoms,and has no obvious adverse reactions.

关 键 词：先兆流产 绒毛膜下血肿 孟河医派安胎核心方 

分 类 号：R271.19[医药卫生—中医妇科学]